Author

Richard P. Shank

Observed names: R P Shank, R. P Shank, R. P. SHANK, R. P. Shank, R.P Shank, R.P. Shank, RP Shank, Richard P Shank, Richard Shank, Shank, Richard Paul

Observed institutions: City Of Hope National Medical Center, United States Department of Veterans Affairs, Johnson & Johnson (United States), University of California, Los Angeles, University of Konstanz, Indiana University Hospital, Franklin Institute, Graduate Hospital, VA Sepulveda Ambulatory Care Center, Larue Carter Hospital, Indiana University Indianapolis, Indiana University School of Medicine, Janssen Research & Development (United States), Indiana University – Purdue University Indianapolis, Indiana University, Temple University

OpenAlex ID: A5090976373

Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic.

1992 · R B Raffa, E Friderichs, et al. · Journal of Pharmacology and Experimental Therapeutics · 1,156

β-Amyloid1–42 Binds to α7 Nicotinic Acetylcholine Receptor with High Affinity

2000 · Hoau-Yan Wang, Daniel H.S. Lee, et al. · Journal of Biological Chemistry · 845

An Overview of the Preclinical Aspects of Topiramate: Pharmacology, Pharmacokinetics, and Mechanism of Action

2000 · Richard P. Shank, Joseph F. Gardocki, et al. · Epilepsia · 811

Pyruvate car☐ylase: an astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools

1985 · Richard P. Shank, Gudrun S. Bennett, et al. · Brain Research · 474

Amyloid Peptide Aβ1‐42 Binds Selectively and with Picomolar Affinity to α7 Nicotinic Acetylcholine Receptors

2000 · Hoau‐Yan Wang, Daniel H. S. Lee, et al. · Journal of Neurochemistry · 441

Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol.

1993 · R B Raffa, E Friderichs, et al. · Journal of Pharmacology and Experimental Therapeutics · 440

Serotonin and norepinephrine uptake inhibiting activity of centrally acting analgesics: structural determinants and role in antinociception.

1995 · E E Codd, R P Shank, et al. · Journal of Pharmacology and Experimental Therapeutics · 386

DISTRIBUTION OF SOME SYNAPTIC TRANSMITTER SUSPECTS IN CAT SPINAL CORD: GLUTAMIC ACID, ASPARTIC ACID, γ‐AMINOBUTYRIC ACID, GLYCINE, AND GLUTAMINE *

1967 · L. T. Graham, R. P. Shank, et al. · Journal of Neurochemistry · 376

Topiramate: Preclinical Evaluation of a Structurally Novel Anticonvulsant

1994 · Richard P. Shank, Joseph F. Gardocki, et al. · Epilepsia · 344

Topiramate as an Inhibitor of Carbonic Anhydrase Isoenzymes

2000 · Susanna J. Dodgson, Richard P. Shank, et al. · Epilepsia · 319

Glutamate as a Neurotransmitter

2018 · Richard P. Shank, M. H. Aprison · CRC Press eBooks · 264

Present status and significance of the glutamine cycle in neural tissues

1981 · R.P. Shank, M.H. Aprison · Life Sciences · 214

Changes in Amino Acid Concentrations Associated With Loss of Spinal Interneurons *

1967 · R. A. Davidoff, L. T. Graham, et al. · Journal of Neurochemistry · 210

Anticonvulsant O-alkyl sulfamates. 2,3:4,5-Bis-O-(1-methylethylidene)-.beta.-D-fructopyranose sulfamate and related compounds

1987 · Bruce E. Maryanoff, Samuel O. Nortey, et al. · Journal of Medicinal Chemistry · 179

The Metabolism in Vivo of Glycine and Serine in Eight Areas of the Rat Central Nervous System1

1970 · R. P Shank, M. H Aprison · Journal of Neurochemistry · 162

Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships

1987 · Bruce E. Maryanoff, David F. McComsey, et al. · Journal of Medicinal Chemistry · 151

A comparison of the concentration of glycine, a transmitter suspect, in different areas of the brain and spinal cord in seven different vertebrates

1969 · M.H Aprison, R.P Shank, et al. · Comparative Biochemistry and Physiology · 150

Molecular Pharmacodynamics, Clinical Therapeutics, and Pharmacokinetics of Topiramate

2008 · Richard P. Shank, Bruce E. Maryanoff · CNS Neuroscience & Therapeutics · 148

PDF

Topiramate as an Inhibitor of Carbonic Anhydrase Isoenzymes

2000 · Susanna J. Dodgson, Richard P. Shank, et al. · Epilepsia · 148

PDF

α‐Ketoglutarate and Malate Uptake and Metabolism by Synaptosomes: Further Evidence for an Astrocyte‐to‐Neuron Metabolic Shuttle

1984 · Richard P. Shank, Graham Le M. Campbell · Journal of Neurochemistry · 144

Cerebral Metabolic Compartmentation as Revealed by Nuclear Magnetic Resonance Analysis of D‐[1‐13C]Glucose Metabolism

1993 · Richard P. Shank, Gregory C. Leo, et al. · Journal of Neurochemistry · 131

Structure−Activity Studies on Anticonvulsant Sugar Sulfamates Related to Topiramate. Enhanced Potency with Cyclic Sulfate Derivatives

1998 · Bruce E. Maryanoff, Michael J. Costanzo, et al. · Journal of Medicinal Chemistry · 121

Plasma and whole blood pharmacokinetics of topiramate: the role of carbonic anhydrase

2005 · Richard P. Shank, Dennis R. Doose, et al. · Epilepsy Research · 108

Topiramate modulation of kainate‐induced calcium currents is inversely related to channel phosphorylation level

2003 · Mikael Ängehagen, Elinor Ben‐Menachem, et al. · Journal of Neurochemistry · 87

Is Glycine a Neurotransmitter ?: Association of Glycine with Spinal Interneurones

1967 · R. A. DAVIDOFF, R. P. SHANK, et al. · Nature · 85

Works count: 124

Citation count: 10,350

H-index: 44

I10-index: 88